CONTEXT: Concussed athletes may underreport concussion-related symptoms in order to expedite return to play. Whether neurocognitive impairments persist once concussion-related symptoms resolve has yet to be determined. Reliance on athlete-reported, postconcussion symptoms when making return-to-play decisions may expose athletes to subsequent injury if complete recovery has not occurred. OBJECTIVE: To evaluate the presence of neurocognitive decrements in concussed athletes no longer reporting concussion-related symptoms. DESIGN: Within-groups design. SETTING: University research laboratory. PATIENTS OR OTHER PARTICIPANTS: Twenty-one National Collegiate Athletic Association Division I collegiate athletes (16 men, 5 women). Age = 19.81 +/- 1.25 years, height = 180.95 +/- 10.62 cm, mass = 93.66 +/- 27.60 kg, and previous concussions = 1.76 +/- 2.02. MAIN OUTCOME MEASURE(S): The ImPACT concussion assessment test was administered to concussed athletes at baseline, when symptomatic (within 72 hours of injury), and when asymptomatic. Index scores of verbal memory, visual memory, visual-motor speed, reaction time, and concussion-related symptoms were recorded at each session. The Symptom Assessment Scale was administered daily after injury to establish when the athlete became asymptomatic. RESULTS: When assessed within 72 hours of concussion, 81% of the athletes showed deficits on at least 1 ImPACT variable. At the asymptomatic time point, 38% of the concussed athletes continued to demonstrate neurocognitive impairment on at least 1 ImPACT variable. CONCLUSIONS: Neurocognitive decrements may persist when athletes no longer report concussion-related symptoms. The exclusive use of symptom reports in making a return-to-play decision is not advised. A multifaceted approach to concussion assessment that includes evaluation of a myriad of functions is warranted.
CONTEXT: Concussed athletes may underreport concussion-related symptoms in order to expedite return to play. Whether neurocognitive impairments persist once concussion-related symptoms resolve has yet to be determined. Reliance on athlete-reported, postconcussion symptoms when making return-to-play decisions may expose athletes to subsequent injury if complete recovery has not occurred. OBJECTIVE: To evaluate the presence of neurocognitive decrements in concussed athletes no longer reporting concussion-related symptoms. DESIGN: Within-groups design. SETTING: University research laboratory. PATIENTS OR OTHER PARTICIPANTS: Twenty-one National Collegiate Athletic Association Division I collegiate athletes (16 men, 5 women). Age = 19.81 +/- 1.25 years, height = 180.95 +/- 10.62 cm, mass = 93.66 +/- 27.60 kg, and previous concussions = 1.76 +/- 2.02. MAIN OUTCOME MEASURE(S): The ImPACT concussion assessment test was administered to concussed athletes at baseline, when symptomatic (within 72 hours of injury), and when asymptomatic. Index scores of verbal memory, visual memory, visual-motor speed, reaction time, and concussion-related symptoms were recorded at each session. The Symptom Assessment Scale was administered daily after injury to establish when the athlete became asymptomatic. RESULTS: When assessed within 72 hours of concussion, 81% of the athletes showed deficits on at least 1 ImPACT variable. At the asymptomatic time point, 38% of the concussed athletes continued to demonstrate neurocognitive impairment on at least 1 ImPACT variable. CONCLUSIONS: Neurocognitive decrements may persist when athletes no longer report concussion-related symptoms. The exclusive use of symptom reports in making a return-to-play decision is not advised. A multifaceted approach to concussion assessment that includes evaluation of a myriad of functions is warranted.
Entities:
Keywords:
ImPACT; concussion; return to play; symptoms
Authors: Kevin M Guskiewicz; Scott L Bruce; Robert C Cantu; Michael S Ferrara; James P Kelly; Michael McCrea; Margot Putukian; Tamara C Valovich McLeod Journal: J Athl Train Date: 2004-09 Impact factor: 2.860
Authors: Philip Schatz; Jamie E Pardini; Mark R Lovell; Michael W Collins; Kenneth Podell Journal: Arch Clin Neuropsychol Date: 2005-09-06 Impact factor: 2.813
Authors: William P Meehan; Pierre d'Hemecourt; Christy L Collins; Alex M Taylor; R Dawn Comstock Journal: Pediatrics Date: 2011-11-30 Impact factor: 7.124
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Robert C Cantu; Jiři Dvořák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard Ellenbogen; Kevin M Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: J Athl Train Date: 2013 Jul-Aug Impact factor: 2.860
Authors: Steven P Broglio; Roberto Vagnozzi; Matthew Sabin; Stefano Signoretti; Barbara Tavazzi; Giuseppe Lazzarino Journal: J Sports Sci Med Date: 2010-09-01 Impact factor: 2.988
Authors: Laurie A King; Fay B Horak; Martina Mancini; Donald Pierce; Kelsey C Priest; James Chesnutt; Patrick Sullivan; Julie C Chapman Journal: Arch Phys Med Rehabil Date: 2013-11-05 Impact factor: 3.966